ReviewFrontiers in molecular biosciences2022

Culprits of PDAC resistance to gemcitabine and immune checkpoint inhibitor: Tumour microenvironment components.

Sheng-Kai Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.